Boston

Biotech By Jonathan Saltzman — Boston Globe

Prominent hospital president resigns from Moderna board after conflict of interest questions raised

Biotech By Damian Garde and Matthew Herper

Coles-led Cerevel Therapeutics to raise $445 million to develop brain drugs with fewer side effects

In the Lab By Elizabeth Cooney

A test you can breathe in: Scientists are developing synthetic biosensors to monitor lung disease

Biotech By Damian Garde

Ruling threatens to upend patents on Moderna’s Covid-19 vaccine

In the Lab By Elizabeth Cooney

‘Inactive’ drug ingredients are not always inactive, study finds

Biotech By Kate Sheridan

Among biotech venture capital firms, Flagship Pioneering got the best single-fund returns 

Health Tech By Rebecca Robbins

Hospitals deploy AI to send patients home earlier — and keep them there

Biotech By Adam Feuerstein

Blueprint Medicines partners with Roche to develop and sell genetically targeted cancer drug

Biotech By Jonathan Saltzman — Boston Globe

Relay Therapeutics, focused on solid tumors, seeks to raise $250M in IPO

Health Tech By Natalya Ortolano

A new tool aims to help patients sort through 200 mental health apps — and counting

Health By Juliet Isselbacher

Women researchers are publishing less since the pandemic hit. What can their employers do to help?

In the Lab By Sharon Begley

Gene-editing discovery could point the way toward a ‘holy grail’: cures for mitochondrial diseases

Hospitals By Sharon Begley

In a new hospital ranking, doing good counts nearly as much as doing well

Pharmalot By Ed Silverman

Alexion to pay $21 million for failing to record bribes paid to doctors in other countries

Pharmalot By Ed Silverman

After years of feuds, Vertex and the U.K. government reach a deal over cystic fibrosis medicines

On the Front Lines By Eric Boodman

In the Covid-19 death of a hospital food worker, a microcosm of the pandemic

Pharmalot By Ed Silverman

Federal prosecutors allege Regeneron used a charity to pay kickbacks to Medicare patients

Biotech By Kate Sheridan

Sana Biotechnology, the secretive startup, lays (some) cards on the table

Health Tech By Rebecca Robbins

Can a prescription video game actually make money? Akili is about to find out

Business By Elizabeth Cooney

A ‘semi-wartime’ effort: Thermo Fisher COO on adapting the business to a Covid-19 world

In the Lab By Elizabeth Cooney

New findings about little-studied cellular compartments could help make chemo more effective

Biotech By Adam Feuerstein

Court invalidates Biogen’s patent on blockbuster multiple sclerosis drug

Health By Sharon Begley

Racial bias skews algorithms widely used to guide care from heart surgery to birth, study finds

Health By Elizabeth Cooney

‘We have a job to do’: Cancer patients and their doctors carry on with clinical trials during Covid-19

Biotech By Adam Feuerstein

Momenta Pharma drug improves symptoms in patients with myasthenia gravis